ArticleMethods in molecular biology (Clifton, N.J.)2026
Chiral High-Performance Liquid Chromatography (HPLC) in Targeted Metabolomics.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enzymatic reactions usually occur with a high substrate, product, or substrate-product stereoselectivity. In many instances, information on the stereochemical disposition of biologically active metabolites is indispensable for a complete understanding of biological processes and metabolic states. This raised interest in structural isomerism and stereoisomerism in metabolomics and lipidomics. While structural and geometrical isomers, as well as diastereomers, can be principally distinguished by achiral liquid chromatography (LC) and also ion-mobility mass spectrometry (MS), enantiomers require enantioselective separation methods. While untargeted enantioselective metabolomics is mostly based on the derivatization of metabolites with a chiral derivatizing agent, followed by LC separation on achiral columns and hyphenation with high-resolution mass spectrometry, targeted enantioselective LC with chiral stationary phases mostly employs robust triple quadrupole (QqQ) mass spectrometry for detection. It is a powerful technology, yet it focuses primarily on a broad, metabolite class-wide coverage. This chapter describes four distinct fields of application of targeted enantioselective LC-tandem mass spectrometry assays for important and representative metabolite classes. The first one deals with the enantioselective analysis of oxylipins using polysaccharide-based chiral columns, with protocols applicable for platelets and plasma; the second focuses on 3-hydroxy fatty acid enantiomer separations in plasma and platelets; the third application provides two workflows for proteinogenic enantioselective amino acid analysis; and the fourth application proposes methodologies for enantioselective short branched-chain fatty acid analysis. Critical aspects are discussed.
Indexed as
Identifiers
41273515What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.